"Having this new location is another step in our strategic growth plan. We continue to see a strong need around balloon component development," says Todd McFarland, President of Biomerics FMI. "Our focus will be on next-generation technologies, including micro- and sensing balloons. Additionally, the facility will provide more capacity to support our strategic customers in the interventional markets we serve."
"Biomerics strongly believes in fielding teams with excellent skillsets. We think it is essential to use an exploratory approach to designing and developing balloon components for a variety of critical medical device applications," says CEO Travis Sessions. "Jhovanny and his team will be the key to success for this facility, and we have every belief that he will thrive. We are always looking for new ways to innovate as it is the lifeblood of any company and adding a location here in Ireland helps us magnify our efforts and strengthen our vision."
Ad Statistics
Times Displayed: 27697
Times Visited: 616 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Global Head of Life Sciences at IDA Ireland Michael Lohan said: "Biomerics' decision to locate its first European site in Galway is terrific news for Ireland and reflects the established Lifesciences cluster in the West Region. This announcement is an exemplar of IDA Ireland's continued commitment to winning innovative investments and job creation in regional locations. I wish Biomerics every success with this investment."
About Biomerics
Founded in 1994, Biomerics is the leading vertically integrated medical device contract manufacturer serving the interventional device market. Trusted as a partner with extensive engineering expertise and solutions, Biomerics supplies 20 of the top 30 medical device OEMs. Biomerics provides engineering design and development services, technical transfer manufacturing services, and contract manufacturing services – including sterilization and packaging - for medical devices components, subassemblies, and finished medical devices through eight locations in the United States, Ireland, and Costa Rica – to meet immediate and long-term strategic needs. With our engineering Centers of Excellence, Biomerics is a leader in materials & compounding, injection molding, complex extrusion, micromachining of metals & polymers, laser processing, balloons & balloon catheters, advanced catheters & steerables, image guided intervention, and finished device assembly. In addition to operating under a certified ISO 13485:2016 quality system, Biomerics is both FDA registered and compliant with FDA 81 CFR Part 820.
SOURCE Biomerics, LLC
Back to HCB News
